Co-localization of suramin and serum albumin in lysosomes of suramin-treated human colon cancer cells

Cancer Letters

Volumn 101, Issue 2, 1996, Pages 179-184

  Baghdiguian, S ^a   Boudier, J A ^b   Boudier, J L ^b   Fantini, J ^c  

^a UNIV MONTPELLIER   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

Cancer; HT 29 D4 cells; Lysosomal; Serum albumin; Suramin

Indexed keywords

COLLOIDAL GOLD; SERUM ALBUMIN; SURAMIN; TRITIUM;

ARTICLE; AUTORADIOGRAPHY; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; LYSOSOME; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

TRITIUM;

EID: 0029881891     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04132-8     Document Type: Article

References (28)

1. Hawking, F. (1978) Suramin: with special reference to onchocerciasis. Adv. Pharmacol. Chemother., 15, 289-322.
2. De Clerq, E. (1979) Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses. Cancer Lett., 8, 9-22.
3. Mitsuya, H., Popovic, M., Yarchoan, R., Matsushita, S., Gallo, R.C. and Broder, S. (1984) Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III. Science, 226, 172-174.
4. Stein, CA. (1993) Suramin: a novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res., 53, 2239-2248.
5. Akanji, M.A. (1988) Rat kidney lysosomal membrane damage induced by suramin in vitro and in vivo. Pharmacol. Toxicol., 62, 318-321.
6. Buys, C.M., Bouma, J.M.W., Gruber, M. and Wisse, E. (1978) induction of lysosomal storage by suramin. Arch. Pharmacol., 304, 183-190.
7. Vakulin, G.M., Korolenko, T.A., Pupyshev, A.B., Malygin, A.E. and Kurysheva, N.G. (1986) Effect of the lysosomotropic preparation suramin on the ultrastructural and functional characteristics of rat liver cells in acute toxic hepatitis. Tsitologiia, 28, 854-861.
8. Rees, S. (1978) Membranous neuronal and neuroglial inclusions produced by intracerebral injection of suramin. J. Neurol. Sci., 36, 97-109.
9. Marjomäki, V. and Salminen, A. (1986) Morphological and enzymatic heterogeneity of suramin-induced lysosomal storage disease in some tissues of mice and rats. Exp. Mol. Pathol., 45, 76-83.
10. Holland, E.J., Stein, C.A. and Palestine, A.G. (1988) Suramin keratopathy. Am. J. Ophthalmol., 106, 216-220.
11. Rees, S., Constantopoulos, G., Barranger, J.A. and Brady, R.O. (1982) Organomegaly and histopathology in an animal model of mucopolysaccharidosis induced by suramin. Naunyn-Schmiedeberg's Arch. Pharmacol., 319, 262-270.
12. Constantopoulos, G., Rees, S., Cragg, B.G., Barranger, J.A. and Brady, O. (1980) Experimental model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat. Proc. Natl. Acad. Sci. USA, 77, 3700-3704.
13. Gritli, A., Septier, D. and Goldberg, M. (1993) Suramin-induced mucopolysaccharidosis in rat incisor. Cell. Tissue Res., 273, 53-64.
14. Baghdiguian, S., Verrier, B., Marvaldi, J. and Fantini, J. (1991) Kinetics of biochemical, electrophysiological and morphological events (including lysosomal disorder) during the course of suramin-induced differentiation of the human colon cancer cell clone HT29-D4. Int. J. Cancer, 49, 608-615.
15. Baghdiguian, S., Verrier, B., Marvaldi, J. and Fantini, J. (1992) Short-term suramin treatment followed by the removal of the drug induces terminal differentiation of HT29-D4 cells. J. Cell. Physiol., 150, 168-174.
16. Baghdiguian, S., Boudier, J.L., Boudier, J.A. and Fantini, J. (1995) Intracellular localization of suramin, an anticancer drug, in human colon adenocarcinoma cells: a study by quantitative autoradiography. Eur. J. Cancer, in press.
17. Fantini, J., Guo, X.J., Marvaldi, J. and Rougon, G. (1990) Suramin inhibits proliferation of rat glioma cells and alters N-CAM cell surface expression. Int. J. Cancer, 45, 554-561.
18. Yahi, N., Sabatier, J.M., Nickel, P., Mabrouk, K., Gonzalez-Scarano, F. and Fantini J. (1994) Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp 120 to galactosylceramide, the receptor for HIV-1 gp 120 on human colon epithelial cells. J. Biol. Chem., 269, 24349-24353.
19. Larra, F. and Droz, B. (1970) Techniques radioautographiques et leur application au renouvellement des constituants cellulaires. J. Microsc. (Paris), 9, 845-880.
20. Windholz, M. (1983) The Merck Index, 10th edn. Merck and Co, Rahway, NJ.
21. Armand, J.P. and Cvitkovic, E. (1990) Suramin a new therapeutic concept. Eur. J. Cancer, 26, 417-419.
22. Muller, W.E. and Wollert, U. (1976) Spectroscopic studies on the complex formation of suramin with bovine and human serum albumin. Biochim. Biophys. Acta, 427, 465-480.
23. Constantopoulos, G., Rees, S., Cragg, B.G., Barranger, J.A. and Brady, O. (1981) Effect of suramin on the activities of degradative enzymes of sphingolipids in rats. Res. Commun. Chem. Pathol. Pharm., 32, 87-97.
24. Constantopoulos, G., Rees, S., Cragg, B.G., Barranger, J.A. and Brady, O. (1981) Differential inhibition of β-hexosaminidase A and β-hexosaminidase B by suramin. Biochem. Biophys. Res. Commun., 101, 1345-1349.
25. Baghdiguian, S., Boudier, J.A., Verrier, B., Zappitelli, J.P. and Fantini, J. (1992) Suramin elicits a lysosomal storage disorder in HT29-D4 cells by a mechanism of polarized endocytosis. C.R. Acad. Sci. Paris, 314 (III), 67-73.
26. Baghdiguian, S., Boudier, J.A., Boudier, J.L. and Fantini, J. (1993) Autoradiographic localization of tritiated suramin in polarized human colon adenocarcinoma cells. Cancer Lett., 75, 151-156.
27. Baghdiguian, S., Nickel, P., Marvaldi, J. and Fantini, J. (1990) A suramin derivative induces enterocyte-like differentiation of human colon cancer cells without lysosomal storage disorders. Anti-Cancer Drugs, 1, 59-66.
28. Baghdiguian, S., Nickel, P. and Fantini, J. (1991) Double screening of suramin derivatives on human colon cancer cells and on neural cells provides new therapeutic agents with reduced toxicity. Cancer Lett., 60, 213-219.